Abnormal activation of AP-1 is associated with lung cancer progression and metastasis, as it plays a crucial role in lung cancer biology, influencing proliferation, invasion, metastasis, and resistance to treatment, contributing to tumour progression and to the creation of an environment conducive to cancer cell survival [54]. Here, FOS is linked to lung carcinoma.